Fact CheckerSign in

NCT06416150Recruiting

Reducing Urban Cervical Cancer Disparities

Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance

Source: ClinicalTrials.gov · Last updated 26 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
546 (estimated)
First submitted
9 Apr 2024
Start date
28 Aug 2024
Primary completion date
Apr 2027
Lead sponsor
Fox Chase Cancer Center
NCT number
NCT06416150

What you commit to

  • Study type: Interventional
  • Planned participants: 546
  • From 28 Aug 2024 to the primary completion date, Apr 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • display current evidence or have a history of positive invasive carcinoma of the cervix, or

Other

  • are pregnant at the time of recruitment,
  • require follow-up but not a colposcopy.

Who the study is looking for

  • 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
  • referral for colposcopic evaluation at the clinic sites,
  • able to communicate with ease in English,
  • have a cell phone with texting ability, and
  • competent to give consent.

Age in the registry: 18 years to 90 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rutgers, The State University of New Jersey
Coordinator of this site? Confirm its status
New BrunswickUnited StatesRecruiting
Thomas Jefferson University
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Fox Chase Cancer Center
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.